Quarterly ResultJul 31, 2026, 06:03 AM
BrightSpring Q2 Revenue +23% to $3.87B; Net Income $87M; Raises FY26 Guidance
AI Summary
BrightSpring Health Services reported strong second-quarter 2026 financial results, with net revenue increasing 23.0% to $3.87 billion and net income reaching $87 million, a significant rise from $9 million in Q2 2025. The company also announced an increase in its full-year 2026 revenue and Adjusted EBITDA guidance. Key corporate actions included a $300 million debt paydown and a $60 million share repurchase.
Key Highlights
- Net revenue increased 23.0% to $3.87 billion in Q2 2026.
- Net income rose to $87 million in Q2 2026 from $9 million in Q2 2025.
- Adjusted EBITDA grew 44.2% to $206 million in Q2 2026.
- Full-year 2026 revenue guidance raised to $15.1B-$15.425B (17.0%-19.5% growth).
- Full-year 2026 Adjusted EBITDA guidance raised to $820M-$845M (32.8%-36.8% growth).
- Completed $300 million paydown of First Lien Facility, reducing leverage to 2.15x.
- Repurchased $60 million of common stock (1,026,465 shares) in Q2 2026.
- Pharmacy Solutions revenue up 22% to $3.407 billion; Provider Services revenue up 30% to $466 million.
Price Impact
More from BTSG